Quality of life after kidney transplantation--the impact of tacrolimus

Transplant Proc. 2001 Feb-Mar;33(1-2):1924-6. doi: 10.1016/s0041-1345(00)02714-7.

Authors

J Reimer¹, G H Franke, P Luetkes, M Kohnle, T Philipp, U Heemann

Affiliation

¹ Department of Nephrology and Hypertension, Center for Internal Medicine, University of Essen, Essen, Germany.

PMID: 11267573
DOI: 10.1016/s0041-1345(00)02714-7

No abstract available

MeSH terms

Case-Control Studies
Cyclosporine / therapeutic use
Female
Follow-Up Studies
Humans
Immunosuppressive Agents / therapeutic use*
Kidney Failure, Chronic / economics
Kidney Failure, Chronic / surgery*
Kidney Transplantation* / economics
Kidney Transplantation* / immunology
Kidney Transplantation* / mortality
Male
Middle Aged
Quality of Life*
Survival Analysis
Tacrolimus / therapeutic use*

Substances

Immunosuppressive Agents
Cyclosporine
Tacrolimus